Vanguard Group Inc Bioventus Inc. Transaction History

Vanguard Group Inc

$6.44 Trillion
Q3 2025

A detailed history of Vanguard Group Inc transactions in Bioventus Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,924,788 shares of BVS stock, worth $21.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,924,788

Previous 2,802,039 4.38%

Holding current value

$21.5 Million

Previous $18.5 Million 5.48%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	BUY	$6.14 - $7.64 $753,678 - $937,802	122,749 Added 4.38%	2,924,788 $19.6 Million
Q2 2025 Aug 11, 2025	BUY	$6.2 - $9.51 $1.54 Million - $2.36 Million	247,815 Added 9.7%	2,802,039 $18.5 Million
Q1 2025 May 09, 2025	BUY	$8.76 - $11.05 $807,172 - $1.02 Million	92,143 Added 3.74%	2,554,224 $23.4 Million
Q4 2024 Feb 11, 2025	BUY	$10.5 - $13.71 $4.08 Million - $5.32 Million	388,174 Added 18.72%	2,462,081 $25.9 Million
Q3 2024 Nov 13, 2024	BUY	$5.73 - $11.95 $2.37 Million - $4.94 Million	413,241 Added 24.88%	2,073,907 $24.8 Million
Q2 2024 Aug 13, 2024	BUY	$3.96 - $6.93 $1.75 Million - $3.06 Million	442,166 Added 36.29%	1,660,666 $9.55 Million
Q4 2023 Feb 14, 2024	BUY	$2.89 - $5.34 $50,343 - $93,022	17,420 Added 1.45%	1,218,500 $6.42 Million
Q3 2023 Nov 14, 2023	BUY	$2.8 - $4.94 $15,870 - $27,999	5,668 Added 0.47%	1,201,080 $3.96 Million
Q2 2023 Aug 14, 2023	SELL	$0.93 - $3.64 $126,498 - $495,112	-136,020 Reduced 10.22%	1,195,412 $3.45 Million
Q1 2023 May 15, 2023	SELL	$1.07 - $2.95 $15,941 - $43,952	-14,899 Reduced 1.11%	1,331,432 $1.42 Million
Q4 2022 Feb 10, 2023	BUY	$1.81 - $8.14 $293,989 - $1.32 Million	162,425 Added 13.72%	1,346,331 $3.51 Million
Q3 2022 Nov 14, 2022	BUY	$6.54 - $9.08 $1.25 Million - $1.74 Million	191,671 Added 19.32%	1,183,906 $8.29 Million
Q2 2022 Aug 12, 2022	SELL	$6.82 - $13.82 $878,613 - $1.78 Million	-128,829 Reduced 11.49%	992,235 $6.77 Million
Q1 2022 May 13, 2022	SELL	$11.65 - $15.28 $5.07 Million - $6.65 Million	-435,365 Reduced 27.97%	1,121,064 $15.8 Million
Q4 2021 Feb 14, 2022	BUY	$12.37 - $16.77 $9.31 Million - $12.6 Million	752,650 Added 93.64%	1,556,429 $22.6 Million
Q3 2021 Nov 12, 2021	BUY	$13.7 - $17.25 $3.92 Million - $4.94 Million	286,286 Added 55.32%	803,779 $11.4 Million
Q2 2021 Aug 13, 2021	BUY	$13.75 - $18.8 $7.12 Million - $9.73 Million	517,493 New	517,493 $9.11 Million

Others Institutions Holding BVS

# of Institutions

143

Shares Held

50.1M

Call Options Held

42.5K

Put Options Held

100K

View Full List

About Bioventus Inc.

Ticker BVS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 61,664,200
Market Cap $453M
Description
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...

More about BVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Bioventus Inc. Transaction History